Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer

Canonical prefoldin is a protein cochaperone composed of six di erent subunits (PFDN1 to 6). PFDN1 overexpression promotes epithelial–mesenchymal transition (EMT) and increases the growth of xenograft lung cancer (LC) cell lines. We investigated whether this putative involvement of canonical PFDN in...

Full description

Bibliographic Details
Authors: Peñate Salas, Xenia; Praena Fernández, Juan Manuel; Romero Pareja, Pedro; Enguix Riego, María del Valle; Payán Bravo, Laura; Vieites Pérez-Quintela, Begoña; Chávez de Diego, Sebastián; López Guerra, José Luis
Format: Article
Status:Published version
Publication date:2020
Country:España
Institution:Universidad de Sevilla (US)
Repository:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/98291
Online Access:https://hdl.handle.net/11441/98291
https://doi.org/10.3390/cancers12041052
Access Level:Open access
Keyword:Prefoldin
Metastasis
Survival
Non-small cell lung cancer
_version_ 1878739117368410112
author Peñate Salas, Xenia
author2 Praena Fernández, Juan Manuel
Romero Pareja, Pedro
Enguix Riego, María del Valle
Payán Bravo, Laura
Vieites Pérez-Quintela, Begoña
Chávez de Diego, Sebastián
López Guerra, José Luis
author2_role author
author
author
author
author
author
author
author_browse Chávez de Diego, Sebastián
Enguix Riego, María del Valle
López Guerra, José Luis
Payán Bravo, Laura
Peñate Salas, Xenia
Praena Fernández, Juan Manuel
Romero Pareja, Pedro
Vieites Pérez-Quintela, Begoña
author_facet Peñate Salas, Xenia
Praena Fernández, Juan Manuel
Romero Pareja, Pedro
Enguix Riego, María del Valle
Payán Bravo, Laura
Vieites Pérez-Quintela, Begoña
Chávez de Diego, Sebastián
López Guerra, José Luis
author_role author
collection idUS. Depósito de Investigación de la Universidad de Sevilla
description Canonical prefoldin is a protein cochaperone composed of six di erent subunits (PFDN1 to 6). PFDN1 overexpression promotes epithelial–mesenchymal transition (EMT) and increases the growth of xenograft lung cancer (LC) cell lines. We investigated whether this putative involvement of canonical PFDN in LC translates into the clinic. First, the mRNA expression of 518 non-small cell LC (NSCLC) cases from The Cancer Genome Atlas (TCGA) database was evaluated. Patients with PFDN1 overexpression had lower overall survival (OS; 45 vs. 86 months; p = 0.034). We then assessed the impact of PFDN expression on outcome in 58 NSCLC patients with available tumor tissue samples. PFDN1, 3, and 5 overexpression were found in 38% (n = 22), 53% (n = 31), and 41% (n = 24) of tumor samples. PFDN1, 3, and 5 overexpression were significantly associated with lower OS, lower disease-free survival (DFS), and lower distant metastasis-free survival (DMFS) for PFDN1 and 3 with a trend for PFDN5. In multivariate analysis, PFDN5 retained significance for OS (hazard ratio (HR) 2.56; p = 0.007) and PFDN1 for DFS (HR 2.53; p = 0.010) and marginally for DMFS (HR 2.32; p = 0.053). Our results indicate that protein response markers, such as PFDN1, 3, and 5, may complement mRNA signatures and be useful for determining the most appropriate therapy for NSCLC patients.
eu_rights_str_mv openAccess
format article
id ES_bb66dfdb31d78bc8900a8ed4bf521574
institution Universidad de Sevilla (US)
instname_str Universidad de Sevilla (US)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:idus.us.es:11441/98291
publishDate 2020
publishDateSort 2020
reponame_str idUS. Depósito de Investigación de la Universidad de Sevilla
spelling Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer Peñate Salas, Xenia Praena Fernández, Juan Manuel Romero Pareja, Pedro Enguix Riego, María del Valle Payán Bravo, Laura Vieites Pérez-Quintela, Begoña Chávez de Diego, Sebastián López Guerra, José Luis Prefoldin Metastasis Survival Non-small cell lung cancer Canonical prefoldin is a protein cochaperone composed of six di erent subunits (PFDN1 to 6). PFDN1 overexpression promotes epithelial–mesenchymal transition (EMT) and increases the growth of xenograft lung cancer (LC) cell lines. We investigated whether this putative involvement of canonical PFDN in LC translates into the clinic. First, the mRNA expression of 518 non-small cell LC (NSCLC) cases from The Cancer Genome Atlas (TCGA) database was evaluated. Patients with PFDN1 overexpression had lower overall survival (OS; 45 vs. 86 months; p = 0.034). We then assessed the impact of PFDN expression on outcome in 58 NSCLC patients with available tumor tissue samples. PFDN1, 3, and 5 overexpression were found in 38% (n = 22), 53% (n = 31), and 41% (n = 24) of tumor samples. PFDN1, 3, and 5 overexpression were significantly associated with lower OS, lower disease-free survival (DFS), and lower distant metastasis-free survival (DMFS) for PFDN1 and 3 with a trend for PFDN5. In multivariate analysis, PFDN5 retained significance for OS (hazard ratio (HR) 2.56; p = 0.007) and PFDN1 for DFS (HR 2.53; p = 0.010) and marginally for DMFS (HR 2.32; p = 0.053). Our results indicate that protein response markers, such as PFDN1, 3, and 5, may complement mRNA signatures and be useful for determining the most appropriate therapy for NSCLC patients. https://hdl.handle.net/11441/98291 https://doi.org/10.3390/cancers12041052
spellingShingle Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer
Peñate Salas, Xenia
Prefoldin
Metastasis
Survival
Non-small cell lung cancer
status_str publishedVersion
title Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer
title_full Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer
title_fullStr Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer
title_full_unstemmed Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer
title_short Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer
title_sort Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer
topic Prefoldin
Metastasis
Survival
Non-small cell lung cancer
topic_facet Prefoldin
Metastasis
Survival
Non-small cell lung cancer
url https://hdl.handle.net/11441/98291
https://doi.org/10.3390/cancers12041052